Latest news
China approval for TransThera’s Yochanra - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 19:24:48 GMT5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care - The American Journal of Managed Care® (AJMC®)The American Journal of Managed Care® (AJMC®) · Fri, 07 Aug 2026 17:22:29 GMTNew BTK Inhibitor Approved for Urticaria - MedscapeMedscape · Fri, 07 Aug 2026 14:53:14 GMTYochanra® approved in China as world-first for FGFR inhibitor-resistant cancer - European Pharmaceutical ReviewEuropean Pharmaceutical Review · Fri, 07 Aug 2026 12:25:36 GMTTransThera wins first China approval in post-FGFR cholangiocarcinoma - AllSciAllSci · Thu, 06 Aug 2026 16:41:13 GMTCardiologists Weigh Where the First Oral PCSK9 Pill Fits Now That the FDA Has Approved It - Medical DailyMedical Daily · Wed, 05 Aug 2026 16:15:08 GMTVepdegestrant (Veppanu) Approved by FDA - Breast Cancer.orgBreast Cancer.org · Tue, 04 Aug 2026 07:00:00 GMTCentanafadine in ADHD: Clinical Significance of the First Triple Reuptake Inhibitor for ADHD - psychiatrictimes.compsychiatrictimes.com · Mon, 03 Aug 2026 18:23:02 GMT